Core Laboratories NV (CLB) Shares Sold by Montag & Caldwell LLC

Paterniano Del Favero
Agosto 13, 2017

Garde Capital Inc. bought a new stake in shares of Core Laboratories N.V. (NYSE:CLB) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The brokerage now has a "hold" rating on the oil and gas company's stock. Ltd.'s holdings in Core Laboratories N.V. were worth $568,000 as of its most recent filing with the SEC.

The following firms have also recently changed their position in CLB. BlackRock Inc. increased its position in Core Laboratories N.V.by 3,736.4% in the first quarter. The value of the total investment in Core Laboratories N.V. went from $67,144,000 to $45,182,000 a change of $21,962,000 quarter over quarter. BidaskClub upgraded shares of Core Laboratories N.V. from a "sell" rating to a "hold" rating in a research report on Wednesday, July 5th. BlackRock Inc. now owns 1,598,608 shares of the oil and gas company's stock worth $184,672,000 after buying an additional 1,556,938 shares during the period. Finally, UBS AG reissued a "neutral" rating and issued a $110.00 target price (down from $125.00) on shares of Core Laboratories N.V.in a report on Wednesday, July 26th. Forward Management LLC now owns 3,569 shares of the oil and gas company's stock valued at $361,000 after buying an additional 215 shares during the period. As of quarter end Stephens Investment Management Group LLC had acquired 23,456 shares growing its position 10.9%. Parallel Advisors LLC now owns 891 shares of the oil and gas company's stock worth $101,000 after buying an additional 223 shares during the period. Core Laboratories N.V. has a one year low of $92.81 and a one year high of $125.83. The stock has a market cap of $4.10 billion, a PE ratio of 57.01 and a beta of 1.60. The company's 50 day moving average price is $101.46 and its 200 day moving average price is $108.84.

Core Laboratories N.V. had a return on equity of 49.29% and a net margin of 11.80%. (NYSE:CLB) last released its quarterly earnings results on Monday, July 24th. In the last earnings report the EPS was $1.63 and is estimated to be $2.09 for the current year with 44,138,000 shares presently outstanding. The firm had revenue of $163.90 million for the quarter, compared to analysts' expectations of $168.23 million. Analysts expect next quarter's EPS will be $0.60 with next year's EPS anticipated to be $2.78.

Shares of Core Laboratories N.V.

Additionally the company recently declared a dividend that will be paid on Monday the 14th of August 2017. Investors of record on Monday, July 17th will be given a $0.55 dividend. The dividend yield will be $2.28. The ex-dividend date will be on Thursday the 13th of July 2017. Analysts predict that Core Laboratories N.V. will post $2.09 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: "B & T Capital Management DBA Alpha Capital Management Has $1.54 Million Stake in Core Laboratories N.V. (NYSE:CLB)" was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece on another publication, it was illegally copied and republished in violation of US & global trademark and copyright laws. The correct version of this story can be read at https://www.baseball-news-blog.com/2017/08/11/garde-capital-inc-takes-position-in-core-laboratories-n-v-clb-updated.html.

A number of brokerages have commented on CLB. ValuEngine raised Core Laboratories N.V. from a "sell" rating to a "hold" rating in a report on Friday, August 4th. Scotiabank set a $136.00 target price on shares of Core Laboratories N.V. and gave the stock a "hold" rating in a research report on Saturday, April 22nd. Royal Bank Of Canada set a $145.00 target price on Core Laboratories N.V. and gave the company a "buy" rating in a research note on Saturday, June 17th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of "Hold" and a consensus target price of $117.17. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE